Medical Product Alert N°3/2024: Falsified (contaminated) Oxymorphone Hydrochloride 40mg Alert Summary This WHO Medical Product Alert refers to one batch of falsified Oxymorphone Hydrochloride 40mg. The falsified product was detected in the unregulated supply chain in Finland and reported to WHO in July 2024 by the Finnish Medicines Agency (FIMEA). Read more…
On July 31st, 24, BBC published an article on the devastating effects surrounding the online purchases of fake semaglutide – an active ingredient in legal drugs like Ozempic, a type 2 diabetes drug, and Wegovy, a weight loss drug. The article interviewed a member of Fight the Fakes Alliance, Oksana Read more…
Our third SF Pulse Issue is out! SF Pulse is a bi-monthly newsletter that aims to elevate important issues and relevant stories shaping the ongoing fight against substandard and falsified medical products (SFs). The newest issue includes 7 important updates across many topics including: A blog post from a financial Read more…
On Friday, 26th July, the FDA, FTFA member USP, and the Asia Pacific Economic Cooperation (APEC) announced the launch of the new web-based version of APEC’s Supply Chain Security (SCS) Toolkit, an essential resource designed to enhance the quality and security of medical products across the global supply chain. Securing Read more…
On July 12, 2024, the New York Times published an article on the rise of counterfeit Ozempic and highlighting the greater risk of buying drugs online. The article interviewed a member of Fight the Fake Alliance, Shabbir Imber Safdar, Executive Director of the Partnership for Safe Medicines. You can access Read more…
On July 4, 2024, Swissinfo published an article on the growing problem of fake medicines on their front page. The article quotes a number of Fight the Fakes Alliance (FTFA) members including the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and the Alliance itself. The piece highlights that Read more…
Fight the Fakes Alliance member, Adam Aspinall, recently attended the Global Health Security Conference in Sydney on behalf of Medicines for Malaria Venture (MMV). At the conference, a forum that engages stakeholders to help achieve a healthier and safer world, Aspinall discussed the need to protect against substandard and falsified Read more…
King’s College London Fight the Fakes will welcome Dr. Asma Buanz in its next webinar about SFs on Thursday, 20 June! The issue of substandard and fake medical products (SFs) has been on the rise with e-commerce platforms providing easy access to such products, and there is an increased need Read more…
Our second SF Pulse Issue is out! SF Pulse is a bi-monthly newsletter that aims to elevate important issues and relevant stories shaping the ongoing fight against substandard and falsified medical products (SFs). Read the full issue here: https://bit.ly/3WJlWDL
King’s College London Fight the Fakes will host a webinar about the response to substandard and falsified (SF) medical products in francophone Sub-Saharan African countries with Raffaella Ravinetto, PharmD, PhD, Head of the Public Health Department, and a professor in pharmaceutical public health, at the Institute of Tropical Medicine (ITM), Read more…